Bidness ETCAbbVie Receives Breakthrough Designation for Cancer DrugDrug Discovery & DevelopmentThe U.S. Food and Drug Administration has granted breakthrough therapy designation for its leukemia drug, to speed up the regulatory review process. On Thursday, AbbVie made the announcement about its venetoclax, an inhibitor of the B-cell lymphoma-2 ...AbbVie gets a 'breakthrough' for one of its top cancer drugsFierceBiotechRoche (AbbVie) declares their leukemia drug 'venetoclax' receives FDA grant for ...Benchmark ReporterFDA Gives Roche Breakthrough Therapy Designation For Venetoclax CLL ...Tech TimesMedical Daily -Newsmaxall 49 news articles »
AbbVie Receives Breakthrough Designation for Cancer Drug
Rating: 4.5
Diposkan Oleh: Unknown
